Journal for ImmunoTherapy of Cancer (Nov 2020)

795 A multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)

  • Michael Wagner,
  • Howard Streicher,
  • Elad Sharon,
  • Razelle Kurzrock,
  • Young Kwang Chae,
  • Megan Othus,
  • Sandip Patel,
  • Edward Mayerson,
  • Christopher Ryan,
  • Melissa Plets,
  • Charles Blanke,
  • Ashish Sangal,
  • Benjamin Powers,
  • George Budd,
  • Adrienne Victor,
  • Chung-Tsen Hsueh,
  • Rashmi Chugh,
  • Suresh Nair,
  • Kirsten Leu,
  • Mark Agulnik

DOI
https://doi.org/10.1136/jitc-2020-SITC2020.0795
Journal volume & issue
Vol. 8, no. Suppl 3

Abstract

Read online

No abstracts available.